Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lublin
Clinical trial register · Poland

Clinical Trials in Lublin, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 95 Lodz 80 Krakow 70 Poznan 67 Gdansk 59
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca44 Janssen Research & Development, LLC36 Hoffmann-La Roche30 Novo Nordisk A/S18 Merck Sharp & Dohme LLC16 Clear sponsor filter
Site location
Warsaw95 Lodz80 Krakow70 Poznan67 Gdansk59
All 81 locations
Target enrolment
to

Trials with a site in Lublin

44 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
AstraZeneca
Phase 3
750
Gdansk, Gliwice, Kielce, Krakow, Lublin, Wroclaw
2026-09-24
Recruiting
AstraZeneca
Phase 3
7,000
Będzin, Bialystok, Czeladź, Gmina Świecie, Katowice, Kwidzyn, Lodz, Lublin
2026-08-21
Recruiting
AstraZeneca
Phase 3
600
Częstochowa, Gdynia, Katowice, Lodz, Lublin, Warsaw
2026-08-12
Recruiting
AstraZeneca
Phase 3
2,000
Bialystok, Częstochowa, Kielce, Lodz, Lublin, Poznan, Radom, Warsaw
2026-07-06
Recruiting
AstraZeneca
Phase 3
1,200
Bialystok, Krakow, Lodz, Lublin, Poznan, Radom, Warsaw
2026-07-06
Recruiting
AstraZeneca
Phase 3
4,500
Bialystok, Bydgoszcz, Kielce, Krakow, Lodz, Lublin, Poznan, Radom
2026-06-29
Recruiting
AstraZeneca
Phase 3
750
Gdansk, Gliwice, Kielce, Lublin, Poznan, Wroclaw
2026-06-26
Recruiting
AstraZeneca
Phase 3
150
Gdansk, Konin, Krakow, Lodz, Lublin, Poznan, Przemyśl, Wroclaw
2026-06-15
Recruiting
AstraZeneca
Phase 2
80
Bydgoszcz, Krakow, Lodz, Lublin, Warsaw
2026-06-04
Recruiting
AstraZeneca
Observational
2,150
Lublin, Krakow, Radom, Bialystok, Częstochowa, Poznan, Warsaw, Lodz
2026-05-06
Recruiting
AstraZeneca
Phase 3
245
Bydgoszcz, Częstochowa, Katowice, Krakow, Lodz, Lublin, Nadarzyn, Nowa Sól
2026-04-13
Recruiting
AstraZeneca
Phase 1
40
Brzozów, Koszalin, Lublin, Olsztyn, Przemyśl
2026-03-31
Recruiting
AstraZeneca
Phase 3
508
Gdansk, Gliwice, Lublin, Poznan, Warsaw, Wroclaw
2026-02-23
Recruiting
AstraZeneca
Phase 3
2,130
Gdansk, Koszalin, Krakow, Lublin, Olsztyn, Warsaw
2026-02-03
Recruiting
AstraZeneca
Phase 2
230
Lublin, Warsaw
2025-12-10
Recruiting
AstraZeneca
Phase 3
420
Kielce, Krakow, Lodz, Lublin, Wroclaw
2025-11-11
Active, closed
AstraZeneca
Phase 3
3,103
Bialystok, Gdansk, Gdynia, Katowice, Kędzierzyn-Koźle, Krakow, Lodz, Lublin
2025-05-28
Recruiting
AstraZeneca
Observational
50
Bydgoszcz, Gdansk, Katowice, Krakow, L DZ, Lublin, Poznan, Szczecin
2025-05-15
Recruiting
AstraZeneca
Phase 3
1,220
Bydgoszcz, Gdansk, Koszalin, Lublin, Olsztyn, Warsaw
2025-05-06
Recruiting
AstraZeneca
Phase 3
5,000
Bialystok, Gdynia, Gmina Świecie, Jasło, Katowice, Krakow, Lodz, Lublin
2025-03-03
Active, closed
AstraZeneca
Observational
105
Bydgoszcz, Bytom, Gdansk, Katowice, Krakow, Lodz, Lublin, Poznan
2025-02-28
Active, closed
Real-life Treatment Outcomes of Ravulizumab in PNH
NCT06633536Paroxysmal Nocturnal Haemoglobinuria
DrugRavulizumab
AstraZeneca
Observational
64
Bialystok, Brzozów, Bydgoszcz, Gdansk, Krakow, Lodz, Lublin, Opole
2025-02-06
Recruiting
AstraZeneca
Phase 3
1,160
Bialystok, Biała Podlaska, Bydgoszcz, Bystra, Lodz, Lublin, Poznan, Warsaw
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Bialystok, Biała Podlaska, Bydgoszcz, Bystra, Lodz, Lublin, Poznan, Warsaw
2024-11-18
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
DrugAZD7798
AstraZeneca
Phase 2
120
Bydgoszcz, Chojnice, Krakow, Lublin, Poznan, Sopot, Warsaw, Wroclaw
2024-08-28
Recruiting
AstraZeneca
Phase 3
620
Bialystok, Katowice, Krakow, Lublin, Warsaw, Wroclaw
2024-08-12
Recruiting
AstraZeneca
Phase 3
1,018
Gdansk, Gliwice, Katowice, Krakow, Lublin, Warsaw, Wroclaw
2024-08-07
Recruiting
AstraZeneca
Phase 3
788
Biała Podlaska, Koszalin, Lodz, Lublin, Poznan, Radom, Warsaw
2024-08-01
Active, closed
AstraZeneca
Phase 3
2,554
Chrzanów, Gdynia, Krakow, Lodz, Lublin, Olsztyn, Poznan, Rzeszów
2024-03-29
Active, closed
AstraZeneca
Phase 3
594
Bielsko-Biala, Gdansk, Katowice, Krakow, Lublin, Słupsk, Warsaw
2024-03-04
Active, closed
AstraZeneca
Phase 3
760
Bydgoszcz, Krakow, Lublin, Przemyśl, Warsaw
2023-12-04
Active, closed
AstraZeneca
Phase 3
895
Lublin, Poznan, Przemyśl, Radom, Warsaw
2023-10-24
Recruiting
AstraZeneca
Phase 3
4,300
Bialystok, Grudziądz, Koszalin, Lodz, Lublin, Opole, Poznan, Racibórz
2023-03-31
Active, closed
AstraZeneca
Phase 3
607
Bydgoszcz, Gdansk, Katowice, Krakow, Lódz, Lublin
2022-09-12
Active, closed
AstraZeneca
Phase 3
927
Bialystok, Biała Podlaska, Bydgoszcz, Koszalin, Lublin, Rzeszów, Warsaw
2021-10-25
Active, closed
AstraZeneca
Phase 3
367
Katowice, Kościan, Krakow, Lodz, Lublin, Nowa Sól, Ustroń, Warsaw
2021-06-08
Active, closed
AstraZeneca
Phase 1
155
Gdansk, Lodz, Lublin, Warsaw
2021-02-02
Active, closed
AstraZeneca
Phase 3
1,371
Gdynia, Konin, Koszalin, Lodz, Lublin, Olsztyn, Poznan
2021-01-28
Active, closed
AstraZeneca
Phase 1/2
245
Bydgoszcz, Koszalin, Lodz, Lublin
2020-12-28
Active, closed
AstraZeneca
Phase 3
185
Bialystok, Grzepnica, Lublin, Olsztyn, Poznan
2020-08-04
Active, closed
AstraZeneca
Phase 3
805
Gdansk, Lodz, Lublin, Olsztyn
2020-05-05
Active, closed
AstraZeneca
Phase 1/2
243
Gdansk, Krakow, Lublin, Opole, Rzeszów, Warsaw
2018-12-21
Active, closed
AstraZeneca
Phase 3
987
Bialystok, Lublin, Olsztyn, Warsaw
2017-03-27
Active, closed
AstraZeneca
Phase 3
669
Bialystok, Grudziądz, Koszalin, Lublin, Mrozy, Warsaw, Wroclaw
2017-01-02
Rows per page Showing 1–44 of 44
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-poland/city/lublin

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 44 of those studies with a site in Lublin that also match the filters currently applied.

How many clinical trials are recruiting in Lublin?

25 of the 44 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 19 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lublin), 44 studies
PhaseStudiesRecruitingShare
Phase 3332075%
Observational429.1%
Phase 2326.8%
Phase 1214.5%
Phase 1/2204.5%

Most active sponsors

Lead sponsors with the most studies (Lublin)
Lead sponsorStudiesRecruiting
AstraZeneca4425
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.